The forecast for Peptic Ulcer and GORD medicine sales in Italy indicates a steady decline from 2024 to 2028. Starting at $1.14 billion in 2024, sales decrease annually by 0.88%, reaching $1.10 billion by 2028. This trend follows a similar pattern observed in previous years, where 2023 figures likely surpassed 2024 estimates, reflecting decreased demand or market saturation.
Future trends to watch for include:
- Developments in treatment alternatives that might affect medicine sales.
- Regulatory changes potentially affecting market dynamics.
- Healthcare policies targeting digestive health improvements.
